Katie M. Davis, DO; Wendie A. Berg, MD, PhD, FACR, FSBI; Marion E. Scoggins, MD
To access 4,300 diagnoses written by the world's leading experts in radiology, please log in or subscribe.Log inSubscribe
0
13
1
0
KEY FACTS
Terminology
Imaging
Top Differential Diagnoses
Pathology
Clinical Issues
TERMINOLOGY
Abbreviations
Lobular carcinoma in situ (LCIS)
Definitions
Classic LCIS: Proliferation of neoplastic cells that fill and expand > 50% of acini in terminal duct lobular units (TDLUs)
Nuclear grade 1 or 2
Loss of E-cadherin and (+) cytoplasmic staining for p120 catenin
Pagetoid spread of monomorphic LCIS cells beneath epithelial layer common
Pleomorphic LCIS: Nuclear grade 3 variant of LCIS
Florid LCIS: Architectural variant of LCIS with massive distention of lobule(s); duct extension, and (often) central necrosis; mimics solid-type DCIS but E-cadherin (-); can be classic or pleomorphic
Risk factor and nonobligate precursor for development of invasive cancer (8-10x risk)
Atypical lobular hyperplasia (ALH): Proliferation of neoplastic cells indistinguishable from LCIS, but of lesser extent, filling < 50% acini in TDLUs without distention
Lobular neoplasia (LN): Morphologic spectrum including ALH and classic LCIS
Some literature uses LN as synonymous with LCIS
WHO classification of lobular intraepithelial lesion (LIN): LIN1 = ALH; LIN2 = LCIS; LIN3 = LCIS variants (pleomorphic, florid)
IMAGING
General Features
Mammographic Findings
Ultrasonographic Findings
MR Findings
Image-Guided Biopsy
Imaging Recommendations
DIFFERENTIAL DIAGNOSIS
PATHOLOGY
General Features
Microscopic Features
CLINICAL ISSUES
Presentation
Demographics
Natural History & Prognosis
Treatment
DIAGNOSTIC CHECKLIST
Consider
Image Interpretation Pearls
Selected References
Marmor S et al: Trends in lobular carcinoma in situ management: endocrine therapy use in California and New Jersey. Cancer Causes Control. ePub, 2019
Donaldson AR et al: Breast cancer risk associated with atypical hyperplasia and lobular carcinoma in situ initially diagnosed on core-needle biopsy. Cancer. 124(3):459-465, 2018
Linsk A et al: Surgical upgrade rate of breast atypia to malignancy: an academic center's experience and validation of a predictive model. Breast J. 24(2):115-119, 2018
Masannat YA et al: Pleomorphic LCIS what do we know? A UK multicenter audit of pleomorphic lobular carcinoma in situ. Breast. 38:120-124, 2018
Schmidt H et al: Observation versus excision of lobular neoplasia on core needle biopsy of the breast. Breast Cancer Res Treat. 168(3):649-654, 2018
Singh K et al: Evaluating agreement, histological features, and relevance of separating pleomorphic and florid lobular carcinoma in situ subtypes. Hum Pathol. 78:163-170, 2018
Speer ME et al: High risk breast lesions identified on MRI-Guided vacuum assisted needle biopsy: outcome of surgical excision and imaging follow-up. Br J Radiol. 20180300, 2018
Wen HY et al: Lobular carcinoma in situ. Surg Pathol Clin. 11(1):123-145, 2018
Mao K et al: Risk of second breast cancers after lobular carcinoma in situ according to hormone receptor status. PLoS One. 12(5):e0176417, 2017
Mullooly M et al: Epidemiologic Risk Factors for In Situ and Invasive Breast Cancers Among Postmenopausal Women in the National Institutes of Health-AARP Diet and Health Study. Am J Epidemiol. 186(12):1329-1340, 2017
Trivedi MS et al: Chemoprevention Uptake among Women with Atypical Hyperplasia and Lobular and Ductal Carcinoma In Situ. Cancer Prev Res (Phila). 10(8):434-441, 2017
Clauser P et al: Management of atypical lobular hyperplasia, atypical ductal hyperplasia, and lobular carcinoma in situ. Expert Rev Anticancer Ther. 16(3):335-46, 2016
Fives C et al: When pathological and radiological correlation is achieved, excision of fibroadenoma with lobular neoplasia on core biopsy is not warranted. Breast. 30:125-129, 2016
Maxwell AJ et al: The radiological features, diagnosis and management of screen-detected lobular neoplasia of the breast: Findings from the Sloane Project. Breast. 27:109-15, 2016
Mooney KL et al: Upgrade rates of high-risk breast lesions diagnosed on core needle biopsy: a single-institution experience and literature review. Mod Pathol. 29(12):1471-1484, 2016
Nakhlis F et al: Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In-situ in Patients with Lobular Neoplasia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 020). Ann Surg Oncol. 23(3):722-8, 2016
Rageth CJ et al: First International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions). Breast Cancer Res Treat. 159(2):203-13, 2016
Renshaw AA et al: Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies. Pathology. 48(1):25-9, 2016
Chang Sen LQ et al: Core Breast Biopsies Showing Lobular Carcinoma In Situ Should Be Excised and Surveillance Is Reasonable for Atypical Lobular Hyperplasia. AJR Am J Roentgenol. 207(5):1132-1145, 2016
McCart Reed AE et al: Invasive lobular carcinoma of the breast: morphology, biomarkers and 'omics. Breast Cancer Res. 17:12, 2015
McEvoy MP et al: Breast Cancer Risk and Follow-up Recommendations for Young Women Diagnosed with Atypical Hyperplasia and Lobular Carcinoma In Situ (LCIS). Ann Surg Oncol. 22(10):3346-9, 2015
Schwartz T et al: Screening breast magnetic resonance imaging in women with atypia or lobular carcinoma in situ. J Surg Res. 193(2):519-22, 2015
Middleton LP et al: Most lobular carcinoma in situ and atypical lobular hyperplasia diagnosed on core needle biopsy can be managed clinically with radiologic follow-up in a multidisciplinary setting. Cancer Med. 3(3):492-9, 2014
Chaudhary S et al: Classic lobular neoplasia on core biopsy: a clinical and radio-pathologic correlation study with follow-up excision biopsy. Mod Pathol. 26(6):762-71, 2013
Scoggins M et al: Lobular carcinoma in situ of the breast: clinical, radiological, and pathological correlation. Acad Radiol. 20(4):463-70, 2013
Ibrahim N et al: Surgical outcome of biopsy-proven lobular neoplasia: is there any difference between lobular carcinoma in situ and atypical lobular hyperplasia? AJR Am J Roentgenol. 198(2):288-91, 2012
Linda A et al: Nonsurgical management of high-risk lesions diagnosed at core needle biopsy: can malignancy be ruled out safely with breast MRI? AJR Am J Roentgenol. 198(2):272-80, 2012
Londero V et al: High-risk breast lesions at imaging-guided needle biopsy: usefulness of MRI for treatment decision. AJR Am J Roentgenol. 199(2):W240-50, 2012
Rendi MH et al: Lobular in-situ neoplasia on breast core needle biopsy: imaging indication and pathologic extent can identify which patients require excisional biopsy. Ann Surg Oncol. 19(3):914-21, 2012
Zhao C et al: Pathologic findings of follow-up surgical excision for lobular neoplasia on breast core biopsy performed for calcification. Am J Clin Pathol. 138(1):72-8, 2012
Friedlander LC et al: Results of MR imaging screening for breast cancer in high-risk patients with lobular carcinoma in situ. Radiology. 261(2):421-7, 2011
Sung JS et al: Screening breast MR imaging in women with a history of lobular carcinoma in situ. Radiology. 261(2):414-20, 2011
Ansquer Y et al: Risk of invasive breast cancer after lobular intra-epithelial neoplasia: review of the literature. Eur J Surg Oncol. 36(7):604-9, 2010
Bevers TB et al: NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis. J Natl Compr Canc Netw. 2009 Nov;7(10):1060-96. Review. Erratum in: J Natl Compr Canc Netw. 8(2):xxxvii, 2010
Gao F et al: Clinical importance of histologic grading of lobular carcinoma in situ in breast core needle biopsy specimens: current issues and controversies. Am J Clin Pathol. 133(5):767-71, 2010
Pediconi F et al: Role of breast MR imaging for predicting malignancy of histologically borderline lesions diagnosed at core needle biopsy: prospective evaluation. Radiology. 257(3):653-61, 2010
Sullivan ME et al: Lobular carcinoma in situ variants in breast cores: potential for misdiagnosis, upgrade rates at surgical excision, and practical implications. Arch Pathol Lab Med. 134(7):1024-8, 2010
Ho BC et al: Lobular neoplasia of the breast: 68 years on. Pathology. 41(1):28-35, 2009
Brem RF et al: Lobular neoplasia at percutaneous breast biopsy: variables associated with carcinoma at surgical excision. AJR Am J Roentgenol. 190(3):637-41, 2008
Hwang H et al: Atypical lobular hyperplasia and classic lobular carcinoma in situ in core biopsy specimens: routine excision is not necessary. Mod Pathol. 21(10):1208-16, 2008
Linda A et al: Borderline breast lesions diagnosed at core needle biopsy: can magnetic resonance mammography rule out associated malignancy? Preliminary results based on 79 surgically excised lesions. Breast. 17(2):125-31, 2008
Londero V et al: Lobular neoplasia: core needle breast biopsy underestimation of malignancy in relation to radiologic and pathologic features. Breast. 17(6):623-30, 2008
Sohn VY et al: Lobular neoplasia: is surgical excision warranted? Am Surg. 74(2):172-7, 2008
Port ER et al: Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia. Ann Surg Oncol. 14(3):1051-7, 2007
Saslow D et al: American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007 Mar-Apr;57(2):75-89. Erratum in: CA Cancer J Clin. 57(3):185, 2007
Anderson BO et al: Evolving concepts in the management of lobular neoplasia. J Natl Compr Canc Netw. 4(5):511-22, 2006
Bevers TB et al: Breast cancer screening and diagnosis. J Natl Compr Canc Netw. 4(5):480-508, 2006
Mahoney MC et al: Lobular neoplasia at 11-gauge vacuum-assisted stereotactic biopsy: correlation with surgical excisional biopsy and mammographic follow-up. AJR Am J Roentgenol. 187(4):949-54, 2006
Bassett LW et al: Breast core needle biopsy: imaging-pathology assessment of results. Breast Imaging: RSNA Categorical Course in Diagnostic Radiology. 55-65, 2005
Garreau JR et al: Risk counseling and management in patients with lobular carcinoma in situ. Am J Surg. 189(5):610-4; discussion 614-5, 2005
Arpino G et al: Lobular neoplasia on core-needle biopsy--clinical significance. Cancer. 101(2):242-50, 2004
Berg WA: Image-guided breast biopsy and management of high-risk lesions. Radiol Clin North Am. 42(5):935-46, vii, 2004
Foster MC et al: Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary? Radiology. 231(3):813-9, 2004
Selinko VL et al: Role of sonography in diagnosing and staging invasive lobular carcinoma. J Clin Ultrasound. 32(7):323-32, 2004
Liberman L et al: Ductal enhancement on MR imaging of the breast. AJR Am J Roentgenol. 181(2):519-25, 2003
Middleton LP et al: Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised? Mod Pathol. 16(2):120-9, 2003
Page DL et al: Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study. Lancet. 361(9352):125-9, 2003
Li CI et al: Changing incidence of lobular carcinoma in situ of the breast. Breast Cancer Res Treat. 75(3):259-68, 2002
Berg WA et al: Atypical lobular hyperplasia or lobular carcinoma in situ at core-needle breast biopsy. Radiology. 218(2):503-9, 2001
Georgian-Smith D et al: Calcifications of lobular carcinoma in situ of the breast: radiologic-pathologic correlation. AJR Am J Roentgenol. 176(5):1255-9, 2001
Rosen PP: Chapter 33. In Rosen's Breast Pathology. Philadelphia, Lippincott Williams & Wilkins. 581-610, 2001
Fisher B et al: Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst. 90(18):1371-88, 1998
Page DL et al: Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol. 22(12):1232-9, 1991
Foote FW et al: Lobular carcinoma in situ: A rare form of mammary cancer. Am J Pathol. 17(4):491-496, 1941
Related Anatomy
Loading...
Related Differential Diagnoses
Loading...
References
Tables
Tables
KEY FACTS
Terminology
Imaging
Top Differential Diagnoses
Pathology
Clinical Issues
TERMINOLOGY
Abbreviations
Lobular carcinoma in situ (LCIS)
Definitions
Classic LCIS: Proliferation of neoplastic cells that fill and expand > 50% of acini in terminal duct lobular units (TDLUs)
Nuclear grade 1 or 2
Loss of E-cadherin and (+) cytoplasmic staining for p120 catenin
Pagetoid spread of monomorphic LCIS cells beneath epithelial layer common
Pleomorphic LCIS: Nuclear grade 3 variant of LCIS
Florid LCIS: Architectural variant of LCIS with massive distention of lobule(s); duct extension, and (often) central necrosis; mimics solid-type DCIS but E-cadherin (-); can be classic or pleomorphic
Risk factor and nonobligate precursor for development of invasive cancer (8-10x risk)
Atypical lobular hyperplasia (ALH): Proliferation of neoplastic cells indistinguishable from LCIS, but of lesser extent, filling < 50% acini in TDLUs without distention
Lobular neoplasia (LN): Morphologic spectrum including ALH and classic LCIS
Some literature uses LN as synonymous with LCIS
WHO classification of lobular intraepithelial lesion (LIN): LIN1 = ALH; LIN2 = LCIS; LIN3 = LCIS variants (pleomorphic, florid)
IMAGING
General Features
Mammographic Findings
Ultrasonographic Findings
MR Findings
Image-Guided Biopsy
Imaging Recommendations
DIFFERENTIAL DIAGNOSIS
PATHOLOGY
General Features
Microscopic Features
CLINICAL ISSUES
Presentation
Demographics
Natural History & Prognosis
Treatment
DIAGNOSTIC CHECKLIST
Consider
Image Interpretation Pearls
Selected References
Marmor S et al: Trends in lobular carcinoma in situ management: endocrine therapy use in California and New Jersey. Cancer Causes Control. ePub, 2019
Donaldson AR et al: Breast cancer risk associated with atypical hyperplasia and lobular carcinoma in situ initially diagnosed on core-needle biopsy. Cancer. 124(3):459-465, 2018
Linsk A et al: Surgical upgrade rate of breast atypia to malignancy: an academic center's experience and validation of a predictive model. Breast J. 24(2):115-119, 2018
Masannat YA et al: Pleomorphic LCIS what do we know? A UK multicenter audit of pleomorphic lobular carcinoma in situ. Breast. 38:120-124, 2018
Schmidt H et al: Observation versus excision of lobular neoplasia on core needle biopsy of the breast. Breast Cancer Res Treat. 168(3):649-654, 2018
Singh K et al: Evaluating agreement, histological features, and relevance of separating pleomorphic and florid lobular carcinoma in situ subtypes. Hum Pathol. 78:163-170, 2018
Speer ME et al: High risk breast lesions identified on MRI-Guided vacuum assisted needle biopsy: outcome of surgical excision and imaging follow-up. Br J Radiol. 20180300, 2018
Wen HY et al: Lobular carcinoma in situ. Surg Pathol Clin. 11(1):123-145, 2018
Mao K et al: Risk of second breast cancers after lobular carcinoma in situ according to hormone receptor status. PLoS One. 12(5):e0176417, 2017
Mullooly M et al: Epidemiologic Risk Factors for In Situ and Invasive Breast Cancers Among Postmenopausal Women in the National Institutes of Health-AARP Diet and Health Study. Am J Epidemiol. 186(12):1329-1340, 2017
Trivedi MS et al: Chemoprevention Uptake among Women with Atypical Hyperplasia and Lobular and Ductal Carcinoma In Situ. Cancer Prev Res (Phila). 10(8):434-441, 2017
Clauser P et al: Management of atypical lobular hyperplasia, atypical ductal hyperplasia, and lobular carcinoma in situ. Expert Rev Anticancer Ther. 16(3):335-46, 2016
Fives C et al: When pathological and radiological correlation is achieved, excision of fibroadenoma with lobular neoplasia on core biopsy is not warranted. Breast. 30:125-129, 2016
Maxwell AJ et al: The radiological features, diagnosis and management of screen-detected lobular neoplasia of the breast: Findings from the Sloane Project. Breast. 27:109-15, 2016
Mooney KL et al: Upgrade rates of high-risk breast lesions diagnosed on core needle biopsy: a single-institution experience and literature review. Mod Pathol. 29(12):1471-1484, 2016
Nakhlis F et al: Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In-situ in Patients with Lobular Neoplasia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 020). Ann Surg Oncol. 23(3):722-8, 2016
Rageth CJ et al: First International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions). Breast Cancer Res Treat. 159(2):203-13, 2016
Renshaw AA et al: Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies. Pathology. 48(1):25-9, 2016
Chang Sen LQ et al: Core Breast Biopsies Showing Lobular Carcinoma In Situ Should Be Excised and Surveillance Is Reasonable for Atypical Lobular Hyperplasia. AJR Am J Roentgenol. 207(5):1132-1145, 2016
McCart Reed AE et al: Invasive lobular carcinoma of the breast: morphology, biomarkers and 'omics. Breast Cancer Res. 17:12, 2015
McEvoy MP et al: Breast Cancer Risk and Follow-up Recommendations for Young Women Diagnosed with Atypical Hyperplasia and Lobular Carcinoma In Situ (LCIS). Ann Surg Oncol. 22(10):3346-9, 2015
Schwartz T et al: Screening breast magnetic resonance imaging in women with atypia or lobular carcinoma in situ. J Surg Res. 193(2):519-22, 2015
Middleton LP et al: Most lobular carcinoma in situ and atypical lobular hyperplasia diagnosed on core needle biopsy can be managed clinically with radiologic follow-up in a multidisciplinary setting. Cancer Med. 3(3):492-9, 2014
Chaudhary S et al: Classic lobular neoplasia on core biopsy: a clinical and radio-pathologic correlation study with follow-up excision biopsy. Mod Pathol. 26(6):762-71, 2013
Scoggins M et al: Lobular carcinoma in situ of the breast: clinical, radiological, and pathological correlation. Acad Radiol. 20(4):463-70, 2013
Ibrahim N et al: Surgical outcome of biopsy-proven lobular neoplasia: is there any difference between lobular carcinoma in situ and atypical lobular hyperplasia? AJR Am J Roentgenol. 198(2):288-91, 2012
Linda A et al: Nonsurgical management of high-risk lesions diagnosed at core needle biopsy: can malignancy be ruled out safely with breast MRI? AJR Am J Roentgenol. 198(2):272-80, 2012
Londero V et al: High-risk breast lesions at imaging-guided needle biopsy: usefulness of MRI for treatment decision. AJR Am J Roentgenol. 199(2):W240-50, 2012
Rendi MH et al: Lobular in-situ neoplasia on breast core needle biopsy: imaging indication and pathologic extent can identify which patients require excisional biopsy. Ann Surg Oncol. 19(3):914-21, 2012
Zhao C et al: Pathologic findings of follow-up surgical excision for lobular neoplasia on breast core biopsy performed for calcification. Am J Clin Pathol. 138(1):72-8, 2012
Friedlander LC et al: Results of MR imaging screening for breast cancer in high-risk patients with lobular carcinoma in situ. Radiology. 261(2):421-7, 2011
Sung JS et al: Screening breast MR imaging in women with a history of lobular carcinoma in situ. Radiology. 261(2):414-20, 2011
Ansquer Y et al: Risk of invasive breast cancer after lobular intra-epithelial neoplasia: review of the literature. Eur J Surg Oncol. 36(7):604-9, 2010
Bevers TB et al: NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis. J Natl Compr Canc Netw. 2009 Nov;7(10):1060-96. Review. Erratum in: J Natl Compr Canc Netw. 8(2):xxxvii, 2010
Gao F et al: Clinical importance of histologic grading of lobular carcinoma in situ in breast core needle biopsy specimens: current issues and controversies. Am J Clin Pathol. 133(5):767-71, 2010
Pediconi F et al: Role of breast MR imaging for predicting malignancy of histologically borderline lesions diagnosed at core needle biopsy: prospective evaluation. Radiology. 257(3):653-61, 2010
Sullivan ME et al: Lobular carcinoma in situ variants in breast cores: potential for misdiagnosis, upgrade rates at surgical excision, and practical implications. Arch Pathol Lab Med. 134(7):1024-8, 2010
Ho BC et al: Lobular neoplasia of the breast: 68 years on. Pathology. 41(1):28-35, 2009
Brem RF et al: Lobular neoplasia at percutaneous breast biopsy: variables associated with carcinoma at surgical excision. AJR Am J Roentgenol. 190(3):637-41, 2008
Hwang H et al: Atypical lobular hyperplasia and classic lobular carcinoma in situ in core biopsy specimens: routine excision is not necessary. Mod Pathol. 21(10):1208-16, 2008
Linda A et al: Borderline breast lesions diagnosed at core needle biopsy: can magnetic resonance mammography rule out associated malignancy? Preliminary results based on 79 surgically excised lesions. Breast. 17(2):125-31, 2008
Londero V et al: Lobular neoplasia: core needle breast biopsy underestimation of malignancy in relation to radiologic and pathologic features. Breast. 17(6):623-30, 2008
Sohn VY et al: Lobular neoplasia: is surgical excision warranted? Am Surg. 74(2):172-7, 2008
Port ER et al: Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia. Ann Surg Oncol. 14(3):1051-7, 2007
Saslow D et al: American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007 Mar-Apr;57(2):75-89. Erratum in: CA Cancer J Clin. 57(3):185, 2007
Anderson BO et al: Evolving concepts in the management of lobular neoplasia. J Natl Compr Canc Netw. 4(5):511-22, 2006
Bevers TB et al: Breast cancer screening and diagnosis. J Natl Compr Canc Netw. 4(5):480-508, 2006
Mahoney MC et al: Lobular neoplasia at 11-gauge vacuum-assisted stereotactic biopsy: correlation with surgical excisional biopsy and mammographic follow-up. AJR Am J Roentgenol. 187(4):949-54, 2006
Bassett LW et al: Breast core needle biopsy: imaging-pathology assessment of results. Breast Imaging: RSNA Categorical Course in Diagnostic Radiology. 55-65, 2005
Garreau JR et al: Risk counseling and management in patients with lobular carcinoma in situ. Am J Surg. 189(5):610-4; discussion 614-5, 2005
Arpino G et al: Lobular neoplasia on core-needle biopsy--clinical significance. Cancer. 101(2):242-50, 2004
Berg WA: Image-guided breast biopsy and management of high-risk lesions. Radiol Clin North Am. 42(5):935-46, vii, 2004
Foster MC et al: Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary? Radiology. 231(3):813-9, 2004
Selinko VL et al: Role of sonography in diagnosing and staging invasive lobular carcinoma. J Clin Ultrasound. 32(7):323-32, 2004
Liberman L et al: Ductal enhancement on MR imaging of the breast. AJR Am J Roentgenol. 181(2):519-25, 2003
Middleton LP et al: Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised? Mod Pathol. 16(2):120-9, 2003
Page DL et al: Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study. Lancet. 361(9352):125-9, 2003
Li CI et al: Changing incidence of lobular carcinoma in situ of the breast. Breast Cancer Res Treat. 75(3):259-68, 2002
Berg WA et al: Atypical lobular hyperplasia or lobular carcinoma in situ at core-needle breast biopsy. Radiology. 218(2):503-9, 2001
Georgian-Smith D et al: Calcifications of lobular carcinoma in situ of the breast: radiologic-pathologic correlation. AJR Am J Roentgenol. 176(5):1255-9, 2001
Rosen PP: Chapter 33. In Rosen's Breast Pathology. Philadelphia, Lippincott Williams & Wilkins. 581-610, 2001
Fisher B et al: Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst. 90(18):1371-88, 1998
Page DL et al: Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol. 22(12):1232-9, 1991
Foote FW et al: Lobular carcinoma in situ: A rare form of mammary cancer. Am J Pathol. 17(4):491-496, 1941
STATdx includes over 200,000 searchable images, including x-ray, CT, MR and ultrasound images. To access all images, please log in or subscribe.